메뉴 건너뛰기




Volumn 5, Issue 6, 2012, Pages 1108-1116

Effects of postmenopausal hormone therapy on incident atrial fibrillation: The Women's Health Initiative randomized controlled trials

(12)  Perez, Marco V a   Wang, Paul J a   Larson, Joseph C b   Virnig, Beth A c   Cochrane, Barbara b,d   Curb, J David e   Klein, Liviu f   Manson, Joann E g,h   Martin, Lisa W i   Robinson, Jennifer j   Wassertheil Smoller, Sylvia k   Stefanick, Marcia L a  


Author keywords

Atrial fibrillation; Hormones; Incidence; Randomized controlled trial; Women

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

EID: 84873866530     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.112.972224     Document Type: Article
Times cited : (52)

References (30)
  • 1
    • 0028921708 scopus 로고
    • Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
    • Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469-473.
    • (1995) Arch Intern Med , vol.155 , pp. 469-473
    • Feinberg, W.M.1    Blackshear, J.L.2    Laupacis, A.3    Kronmal, R.4    Hart, R.G.5
  • 2
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
    • (2001) JAMA , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3    Chang, Y.4    Henault, L.E.5    Selby, J.V.6    Singer, D.E.7
  • 5
    • 79957482449 scopus 로고    scopus 로고
    • Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation
    • Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011;305:2080-2087.
    • (2011) JAMA , vol.305 , pp. 2080-2087
    • Conen, D.1    Chae, C.U.2    Glynn, R.J.3    Tedrow, U.B.4    Everett, B.M.5    Buring, J.E.6    Albert, C.M.7
  • 7
    • 5444249247 scopus 로고    scopus 로고
    • Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study)
    • Copenhagen City Heart Study
    • Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB; Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol. 2004;94:889-894.
    • (2004) Am J Cardiol , vol.94 , pp. 889-894
    • Friberg, J.1    Scharling, H.2    Gadsbøll, N.3    Truelsen, T.4    Jensen, G.B.5
  • 8
    • 0042422040 scopus 로고    scopus 로고
    • A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study
    • Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003;290:1049-1056.
    • (2003) JAMA , vol.290 , pp. 1049-1056
    • Wang, T.J.1    Massaro, J.M.2    Levy, D.3    Vasan, R.S.4    Wolf, P.A.5    D'Agostino, R.B.6    Larson, M.G.7    Kannel, W.B.8    Benjamin, E.J.9
  • 9
    • 33644876790 scopus 로고    scopus 로고
    • Gender difference in subjective symptoms related to paroxysmal atrial fibrillation is also detected in postmenopausal women
    • Sugishita K, Uchida M, Ikeda M, Asakawa M, Sato T, Ito N, Hada Y. Gender difference in subjective symptoms related to paroxysmal atrial fibrillation is also detected in postmenopausal women. Int Heart J. 2005;46:669-678.
    • (2005) Int Heart J , vol.46 , pp. 669-678
    • Sugishita, K.1    Uchida, M.2    Ikeda, M.3    Asakawa, M.4    Sato, T.5    Ito, N.6    Hada, Y.7
  • 10
    • 27744577835 scopus 로고    scopus 로고
    • Gender-related differences in rhythm control treatment in persistent atrial fibrillation: Data of the Rate Control Versus Electrical Cardioversion (RACE) study
    • Rienstra M, Van Veldhuisen DJ, Hagens VE, Ranchor AV, Veeger NJ, Crijns HJ, Van Gelder IC; RACE Investigators. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2005;46:1298-1306.
    • (2005) J Am Coll Cardiol. , vol.46 , pp. 1298-1306
    • Rienstra, M.1    Van Veldhuisen, D.J.2    Hagens, V.E.3    Ranchor, A.V.4    Veeger, N.J.5    Crijns, H.J.6    Van Gelder, I.C.7
  • 12
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Writing Group for the Women's Health Initiative Investigators
    • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3    Lacroix, A.Z.4    Kooperberg, C.5    Stefanick, M.L.6    Jackson, R.D.7    Beresford, S.A.8    Howard, B.V.9    Johnson, K.C.10    Kotchen, J.M.11    Ockene, J.12
  • 14
    • 0142248517 scopus 로고    scopus 로고
    • The Women's Health Initiative postmenopausal hormone trials: Overview and baseline characteristics of participants
    • Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13(9 suppl):S78-S86.
    • (2003) Ann Epidemiol , vol.13 , Issue.9 SUPPL.
    • Stefanick, M.L.1    Cochrane, B.B.2    Hsia, J.3    Barad, D.H.4    Liu, J.H.5    Johnson, S.R.6
  • 15
    • 6844255857 scopus 로고    scopus 로고
    • Design of the Women's Health Initiative clinical trial and observational study
    • The Women's Health Initiative Study Group
    • Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19:61-109.
    • (1998) Control Clin Trials. , vol.19 , pp. 61-109
  • 18
    • 0036357643 scopus 로고    scopus 로고
    • Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo study
    • Oh JY, Barrett-Connor E, Wedick NM, Wingard DL; Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care. 2002;25:55-60.
    • (2002) Diabetes Care. , vol.25 , pp. 55-60
    • Oh, J.Y.1    Barrett-Connor, E.2    Wedick, N.M.3    Wingard, D.L.4
  • 20
    • 0034848736 scopus 로고    scopus 로고
    • Effect of gender on atrial electrophysiologic changes induced by rapid atrial pacing and elevation of atrial pressure
    • Tse HF, Oral H, Pelosi F, Knight BP, Strickberger SA, Morady F. Effect of gender on atrial electrophysiologic changes induced by rapid atrial pacing and elevation of atrial pressure. J Cardiovasc Electrophysiol. 2001;12:986-989.
    • (2001) J Cardiovasc Electrophysiol , vol.12 , pp. 986-989
    • Tse, H.F.1    Oral, H.2    Pelosi, F.3    Knight, B.P.4    Strickberger, S.A.5    Morady, F.6
  • 23
    • 0033578463 scopus 로고    scopus 로고
    • Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
    • Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 1999;100:717-722.
    • (1999) Circulation , vol.100 , pp. 717-722
    • Cushman, M.1    Legault, C.2    Barrett-Connor, E.3    Stefanick, M.L.4    Kessler, C.5    Judd, H.L.6    Sakkinen, P.A.7    Tracy, R.P.8
  • 27
    • 27744481278 scopus 로고    scopus 로고
    • Comorbidity indices to predict mortality from Medicare data: Results from the national registry of atrial fibrillation
    • Yan Y, Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Comorbidity indices to predict mortality from Medicare data: results from the national registry of atrial fibrillation. Med Care. 2005;43:1073-1077.
    • (2005) Med Care , vol.43 , pp. 1073-1077
    • Yan, Y.1    Birman-Deych, E.2    Radford, M.J.3    Nilasena, D.S.4    Gage, B.F.5
  • 28
    • 67049136062 scopus 로고    scopus 로고
    • Incidence of atrial fibrillation in whites and African- Americans: The Atherosclerosis Risk in Communities (ARIC) study
    • Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR. Incidence of atrial fibrillation in whites and African- Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158:111-117.
    • (2009) Am Heart J , vol.158 , pp. 111-117
    • Alonso, A.1    Agarwal, S.K.2    Soliman, E.Z.3    Ambrose, M.4    Chamberlain, A.M.5    Prineas, R.J.6    Folsom, A.R.7
  • 30
    • 84856066615 scopus 로고    scopus 로고
    • A systematic review of validated methods for identifying atrial fibrillation using administrative data
    • Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf. 2012;21(suppl 1): 141-147.
    • (2012) Pharmacoepidemiol Drug Saf. , vol.21 , Issue.SUPPL. 1 , pp. 141-147
    • Jensen, P.N.1    Johnson, K.2    Floyd, J.3    Heckbert, S.R.4    Carnahan, R.5    Dublin, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.